Z:\regulatory Affairs\_compliance\drug Listings\electronic\gateway Submissions\nitroglycerin Sl Tablets\version 7\image-01.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 06)
Nitroglycerin Tablet
Product Images NDC 68462-640
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Nitroglycerin (NDC 68462-640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Z:\regulatory Affairs\_compliance\drug Listings\electronic\gateway Submissions\nitroglycerin Sl Tablets\version 7\image-01.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 07)
Z:\regulatory Affairs\_compliance\drug Listings\electronic\gateway Submissions\nitroglycerin Sl Tablets\version 7\structure.jpg (78127b18 3d0f 4a21 884d Eb7ca2d38b13 08)
Ctn0 3mg
This is a product description for Nitroglycerin Sublingual Tablets, USP, 0.3 mg/tablet manufactured by Glenmark Pharmaceuticals. The tablets are to be dispensed by pharmacists with patient information provided separately for each patient. Each tablet contains 0.3 mg nitroglycerin, and usual dosage information is provided in the prescribing information. The tablets should be stored at room temperature, kept in the original, unopened container, and kept out of reach of children. It is warned that a 'burning or tingling' sensation may be felt at the site of tablet placement, but the lack of such sensations doesn't indicate failure of nitroglycerin release. Medical attention is recommended if the pain persists after three tablets within a 15-minute period or is different from usual. It is also advised to keep the tablets in the original container or a supplemental nitroglycerin container labeled suitable for nitroglycerin sublingual tablets as to not lose potency, and the tablets should not be crushed, chewed or swallowed. Lot and expiry information can be found in the unvarnished area.*
Ctn0 4mg
This is a description of Nitroglycerin Sublingual Tablets, USP. The tablets come in a 0.4mg size and are meant to be dissolved under the tongue. There are 100 tablets per container, and the medication is dispensed by prescription only. The tablets should be stored at between 20-25 degrees Celsius, and dispensed in the original, unopened container. If the pain persists after three tablets have been taken in a 15-minute period or if the pain is different than what is typically experienced, medical attention is recommended. Users may feel a burning or tingling sensation where the tablet is placed, and the user should not swallow the tablets. The medication is manufactured by Glenmark Pharmaceuticals in India and distributed in the USA.*
Ctn0 6mg
This is a product description for Nitroglycerin Sublingual Tablets, USP with a strength of 0.6 mg per tablet, manufactured by Glenmark Pharmaceuticals. It includes instructions for use, usual dosage, and storage information. The tablets are dispensed by a pharmacist and the patient information is provided separately. It also warns users not to crush, chew, or swallow the tablets and to store them in an appropriate container to prevent loss of potency. Contact information for Glenmark Pharmaceuticals is also provided.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
